Reference
Glossary
Plain-language definitions for science, product, health and policy terms.
- Cannabinoid
- A biologically active compound that interacts with cannabinoid receptors in the body. THC and CBD are the best-known cannabinoids.
- THC (Delta-9 THC)
- The primary intoxicating compound in cannabis. Responsible for the 'high' and many of the psychoactive effects.
- CBD (Cannabidiol)
- A non-intoxicating cannabinoid. Biologically active and can interact with medications; retail products differ from prescription medicines.
- THCA
- The acidic, non-intoxicating form of THC found in raw cannabis. Converts partly to THC when heated.
- CBDA
- The acidic precursor to CBD found in raw cannabis plants.
- Endocannabinoid system (ECS)
- A biological system of receptors, signaling molecules and enzymes involved in processes including pain, appetite, memory and stress response.
- CB1 receptor
- Cannabinoid receptor found primarily in the central nervous system. Strongly involved in the intoxicating effects of THC.
- CB2 receptor
- Cannabinoid receptor found in immune and peripheral tissues. Less involved in intoxication than CB1.
- Certificate of Analysis (CoA)
- A laboratory report documenting batch identity, cannabinoid potency, terpene profile and contaminant testing results for a cannabis product.
- Terpene
- Aromatic compounds found in cannabis and many other plants. Terpenes affect aroma but consumer health claims are not established by strong clinical evidence.
- Onset
- The time it takes for cannabis effects to begin after consumption. Varies significantly by route of administration.
- Route of administration
- How cannabis enters the body. Common routes include inhalation (smoking, vaping), oral (edibles, beverages) and sublingual (under the tongue).
- Sublingual
- Absorbed under the tongue. Tinctures held under the tongue may act faster than swallowed products, but timing varies.
- Edible
- A food or beverage product containing cannabis. Slower onset than inhaled forms, longer duration, and higher risk of overconsumption.
- Cannabis use disorder
- A clinical condition in which continued cannabis use causes meaningful problems or becomes difficult to control.
- Tolerance
- A reduced response to a substance over time, often requiring more to achieve the same effect.
- Dependence
- A state in which the body adapts to a substance and withdrawal symptoms occur when it is stopped.
- Contaminant testing
- Laboratory analysis for microbes, mold, pesticides, heavy metals and residual solvents in cannabis products.
- Potency
- The concentration or strength of a cannabinoid, often expressed as a percentage or milligrams.
- Harm reduction
- Public-health strategies that aim to reduce harms from substance use without necessarily requiring abstinence.
- Schedule I
- The federal drug classification for cannabis under the Controlled Substances Act, indicating no accepted medical use and high potential for abuse under federal law.
- Impairment
- A reduction in the ability to think, react, coordinate or make decisions safely. Cannabis can cause impairment even when a person feels subjectively normal.
- Lower-risk use guidelines
- Evidence-based recommendations, such as Health Canada's Lower-Risk Cannabis Use Guidelines, that identify behaviors associated with reduced cannabis-related harms.